Beta Bugs Ltd, a specialist in Black Soldier Fly (BSF) genetics, and FreezeM Cryogenetics Ltd, developer of the patented PauseM® suspended neonate technology, have announced a new strategic partnership. The collaboration will combine Beta Bugs’ genetics with FreezeM’s production technology to deliver enhanced performance for commercial BSF producers.
Beta Bugs’ HiPer-Fly® is a selectively bred Black Soldier Fly strain developed through more than 45 generations of genetic improvement. Its performance has recently been demonstrated in independent trials. FreezeM’s PauseM® technology provides suspended neonates as a standardised biological input for BSF producers, with extended shelf life and high survival rates.
The companies aim to provide commercial insect producers across Europe with a high-performance solution designed to improve productivity, operational efficiency and production reliability.
Under an agreement signed in July, Beta Bugs and FreezeM will establish a HiPer-Fly® breeding population at FreezeM’s production facility in Germany. FreezeM operates a dedicated BSF breeding hub there with its partner Hermetia Baruth GmbH. The colony will provide the foundation for producing HiPer-Fly®-PauseM® suspended neonates, enabling commercial evaluation and test marketing with selected BSF producers.
The companies will undertake a programme of controlled and commercial trials during the second half of 2026 to validate the HiPer-Fly®-PauseM® product under real-world production conditions. The trials will evaluate biological performance throughout the commercial production cycle and demonstrate improvements in consistency, productivity and yield. Full commercialisation is planned for 2027.
Dr Alan Tinch, Chief Executive Officer of Beta Bugs, said: “Beta Bugs has made great strides in developing superior BSF genetics, as shown by recent comparative trials. We are now delighted to be collaborating with FreezeM in bringing genetic improvements to the BSF market in a package which gives producers a reliable starting point for neonates and allows the HiPer-Fly® to achieve its genetic potential for high yield.”
Yuval Gilad, Chief Executive Officer of FreezeM, added: “We are excited to partner with Beta Bugs and to combine the strengths of two complementary technologies. The synergy between Beta Bugs’ advanced HiPer-Fly® genetics and FreezeM’s breeding expertise and proven PauseM® platform creates a consistent, reliable and scalable pathway for delivering high-performance biological inputs to commercial producers.”
The collaboration reflects both companies’ shared commitment to advancing industrial insect farming through innovation. As the BSF industry continues to mature, partnerships between specialist genetics providers and industrial biological production technology companies will play an increasingly important role in supporting commercial scale-up and meeting growing global demand for sustainable protein and circular bioeconomy solutions.
